Literature DB >> 1390173

Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation.

R J Phillips1, M Judge, D Webb, J I Harper.   

Abstract

Dyskeratosis congenita is an inherited disorder characterized by nail dystrophy, skin pigmentary changes, mucosal leukoplakia, pancytopenia and an increased incidence of malignancy. Because of a widely held view that the outcome of bone marrow transplantation in dyskeratosis congenita is poor, this treatment option is sometimes not considered when pancytopenia develops. We present a child currently doing well 3 years after bone marrow transplantation, and review the literature.

Entities:  

Mesh:

Year:  1992        PMID: 1390173     DOI: 10.1111/j.1365-2133.1992.tb00128.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

Review 2.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.